INTT News & Events

Latest data shows the largest indicative borrow rate increases among liquid option names include: Xanadu Quantum Technologies Limited Class B (XNDU) 108.67% +13.18, YIELDMAX MSTR OPTION INCOME STRATEGY ETF (MSTY) 11.79% +2.98, Grace Therapeutics, Inc (GRCE) 4.90% +1.63, Tradr 2X Long QBTS Daily ETF (QBTX) 18.40% +1.61, Direxion S&P Biotech Bear 3X (LABD) 15.74% +1.36, Kodiak AI, Inc. Common Stock (KDK) 31.81% +1.21, Anheuser Busch (BUD) 2.34% +1.07, GraniteShares 2x Long IONQ Daily ETF (IONL) 27.15% +0.91, Grupo Financiero (GGAL) 1.36% +0.59, and inTest (INTT) 3.91% +0.50.

Sees FY26 gross margin of approximately 45% and operating expenses of $55M-$57M. Sees FY26 amortization expense $2.6M and interest expense of $300,000. The effective tax rate for the year is expected to be approximately 18%. Capital expenditures are estimated to be approximately 1% to 2% of revenue.

Sees Q2 gross margin 45%, and operating expenses $13.8M-$14.2M, reflecting typically higher levels in the Q2. Amortization expense is expected to be $700,000. Rich Rogoff, President and CEO said, "Based on our first quarter outperformance, and improving market conditions, we are raising our full year 2026 revenue outlook to $130 million to $135 million, reflecting our confidence in the continued execution of our growth plans for the year. We remain encouraged by the underlying demand trends across our non-semiconductor markets and by early signs of improvement in our back-end Semi funnel. The strength of our backlog, the breadth of our end market exposure, and the discipline of our team give us confidence in our ability to continue to execute similarly."